Search by Drug Name or NDC

    NDC 00536-1279-35 Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5; 120 mg/1; mg/1 Details

    Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5; 120 mg/1; mg/1

    Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Rugby Laboratories. The primary component is CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 00536-1279
    Product ID 0536-1279_3e66138c-cf57-46f7-a402-b58bafb3c3b1
    Associated GPIs 43993002277420
    GCN Sequence Number 048415
    GCN Sequence Number Description cetirizine HCl/pseudoephedrine TAB ER 12H 5 MG-120MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 13866
    HICL Sequence Number 022864
    HICL Sequence Number Description CETIRIZINE HCL/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cetirizine hydrochloride, Pseudoephedrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 5; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Rugby Laboratories
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210719
    Listing Certified Through 2024-12-31

    Package

    NDC 00536-1279-35 (00536127935)

    NDC Package Code 0536-1279-35
    Billing NDC 00536127935
    Package 24 BLISTER PACK in 1 CARTON (0536-1279-35) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2020-03-09
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.59013
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description CETIRIZINE-PSE ER 5-120 MG TAB
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 5c6ac9a2-4f0a-4297-9b83-988d54598f75 Details

    Revised: 7/2020